Cancer Genetics Secures $5,500,000 New Financing Round

  • Feed Type
  • Date
    12/7/2016
  • Company Name
    Cancer Genetics
  • Mailing Address
    133 Southcenter Court Rutherford, NC 27560 USA
  • Company Description
    Cancer Genetics, Inc. develops, commercializes, and provides molecular and biomarker-based tests and services in the United States, India, and China.
  • Website
    http://www.cancergenetics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $5,500,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 16 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy